New Zealand markets open in 3 hours 46 minutes

BioCorRx Inc. (BICX)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.7300-0.0500 (-6.41%)
As of 12:57PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 7.02M
Enterprise value 9.12M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)119.92
Price/book (mrq)209.37
Enterprise value/revenue 174.27
Enterprise value/EBITDA -4.19

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-59.17%
S&P500 52-week change 324.78%
52-week high 32.2200
52-week low 30.6720
50-day moving average 30.9540
200-day moving average 31.1742

Share statistics

Avg vol (3-month) 3958
Avg vol (10-day) 3670
Shares outstanding 59.61M
Implied shares outstanding 69.98M
Float 83.85M
% held by insiders 156.16%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 322 Jan 2019
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 322 Jan 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-26,759.45%

Management effectiveness

Return on assets (ttm)-450.54%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)52.34k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-91.00%
Gross profit (ttm)N/A
EBITDA -3.67M
Net income avi to common (ttm)-3.99M
Diluted EPS (ttm)-0.4600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)101.08k
Total cash per share (mrq)0.01
Total debt (mrq)2.18M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.02
Book value per share (mrq)-1.21

Cash flow statement

Operating cash flow (ttm)-1.8M
Levered free cash flow (ttm)-731.48k